C. Aceijas, G. V. Stimson, M. Hickman, and T. Rhodes, Global overview of injecting drug use and HIV infection among injecting drug users, AIDS, vol.18, issue.17, pp.18-2295, 2004.
DOI : 10.1097/00002030-200411190-00010

F. L. Altice, G. H. Friedland, and E. L. Cooney, Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone, AIDS, vol.13, issue.8, pp.13-957, 1999.
DOI : 10.1097/00002030-199905280-00012

A. Ammassari, A. Antinori, M. S. Aloisi, M. P. Trotta, R. Murri et al., Depressive symptoms, neurocognitive impairment, and adherence to highly active anti-retroviral therapy among HIV-infected persons, Psychosomatics, issue.5, pp.45-394, 2004.

A. Ammassari, R. Murri, P. Pezzotti, M. P. Trotta, L. Ravasio et al., Self-Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.28, issue.5, pp.445-449, 2001.
DOI : 10.1097/00042560-200112150-00006

C. Andreo, A. D. Bouhnik, J. Soletti, D. R. Bertholon, J. P. Moatti et al., Non-compliance in HIV-infected patients, supported by a community association, pp.249-262, 2001.

A. F. Angelino and G. J. Treisman, Management of Psychiatric Disorders in Patients Infected with Human Immunodeficiency Virus, Clinical Infectious Diseases, vol.33, issue.6, pp.847-856, 2001.
DOI : 10.1086/322679

. Anon, Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction, JAMA, issue.22, pp.280-1936, 1998.

B. Spire, Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST), International Journal of Drug Policy, vol.18, issue.4, pp.262-270, 2007.
DOI : 10.1016/j.drugpo.2006.12.014
URL : https://hal.archives-ouvertes.fr/inserm-00167847

J. H. Arnsten, P. A. Demas, R. W. Grant, M. N. Gourevitch, H. Farzadegan et al., Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users, Journal of General Internal Medicine, vol.33, issue.5, pp.377-381, 2002.
DOI : 10.1007/s11606-002-0044-3

D. R. Bangsberg, E. P. Acosta, R. Gupta, D. Guzman, E. D. Riley et al., Adherence???resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness, AIDS, vol.20, issue.2, pp.223-231, 2006.
DOI : 10.1097/01.aids.0000199825.34241.49

D. R. Bangsberg, E. D. Charlebois, R. M. Grant, M. Holodniy, S. G. Deeks et al., High levels of adherence do not prevent accumulation of HIV drug resistance mutations, AIDS, vol.17, issue.13, pp.17-1925, 2003.
DOI : 10.1097/00002030-200309050-00011

D. R. Bangsberg, S. Perry, E. D. Charlebois, R. A. Clark, M. Roberston et al., Non-adherence to highly active anti-retroviral therapy predicts progression to AIDS, AIDS, issue.9, pp.15-1181, 2001.
DOI : 10.1097/00002030-200106150-00015

S. Bassetti, M. Battegay, H. Furrer, M. Rickenbach, M. Flepp et al., Why is highly active anti-retroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study, J. Acquir. Immune Defic. Syndr, vol.21, issue.2, pp.114-119, 1999.

K. M. Berg, P. A. Demas, A. A. Howard, E. E. Schoenbaum, M. N. Gourevitch et al., Gender differences in factors associated with adherence to antiretroviral therapy, Journal of General Internal Medicine, vol.28, issue.suppl 1, pp.1111-1117, 2004.
DOI : 10.1111/j.1525-1497.2004.30445.x

A. D. Bouhnik, M. P. Carrieri, D. Rey, B. Spire, J. A. Gastaut et al., Drug injection cessation among HIV-infected injecting drug users, Addictive Behaviors, vol.29, issue.6, pp.1189-1197, 2004.
DOI : 10.1016/j.addbeh.2004.01.006

A. D. Bouhnik, M. Chesney, P. Carrieri, H. Gallais, J. Moreau et al., Nonadherence Among HIV-Infected Injecting Drug Users: The Impact of Social Instability, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.31, pp.31-149, 2002.
DOI : 10.1097/00126334-200212153-00013

A. D. Bouhnik, M. Preau, E. Vincent, M. P. Carrieri, H. Gallais et al., Depression and clinical progression in HIV-infected drug users treated with highly active anti-retroviral therapy, Antivir. Ther, vol.10, issue.1, pp.53-61, 2005.

M. G. Brook, A. Dale, D. Tomlinson, C. Waterworth, D. Daniels et al., Adherence to Highly Active Antiretroviral Therapy in the Real World: Experience of Twelve English HIV Units, AIDS Patient Care and STDs, vol.15, issue.9, pp.491-494, 2001.
DOI : 10.1089/108729101753145484

R. K. Brooner, V. L. King, M. Kidorf, C. W. Schmidt, . Jr et al., Psychiatric and Substance Use Comorbidity Among Treatment-Seeking Opioid Abusers, Archives of General Psychiatry, vol.54, issue.1, pp.71-80, 1997.
DOI : 10.1001/archpsyc.1997.01830130077015

C. C. Carpenter, M. A. Fischl, S. M. Hammer, M. S. Hirsch, D. M. Jacobsen et al., Antiretroviral Therapy for HIV Infection in 1998, JAMA, vol.280, issue.1, pp.78-86, 1998.
DOI : 10.1001/jama.280.1.78

M. P. Carrieri, M. A. Chesney, B. Spire, A. Loundou, A. Sobel et al., Failure to maintain adherence to haart in a cohort of French HIV-positive injecting drug users, International Journal of Behavioral Medicine, vol.35, issue.2, pp.1-14, 2003.
DOI : 10.1207/S15327558IJBM1001_01

M. P. Carrieri, C. Leport, C. Protopopescu, J. P. Cassuto, E. Bouvet et al., Factors Associated With Nonadherence to Highly Active Antiretroviral Therapy, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.41, issue.4, pp.477-485, 2006.
DOI : 10.1097/01.qai.0000186364.27587.0e

M. P. Carrieri, J. P. Moatti, D. Vlahov, Y. Obadia, C. Reynaud-maurupt et al., Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group, Journal of Epidemiology & Community Health, vol.53, issue.1, pp.4-8, 1999.
DOI : 10.1136/jech.53.1.4

M. P. Carrieri, F. Raffi, C. Lewden, A. Sobel, C. Michelet et al., Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: A 3-year follow-up study, Antivir. Ther, vol.8, issue.6, pp.585-594, 2003.

M. P. Carrieri, D. Rey, A. Loundou, G. Lepeu, A. Sobel et al., Evaluation of buprenorphine maintenance treatment in a French cohort of HIV-infected injecting drug users, Drug and Alcohol Dependence, vol.72, issue.1, pp.13-21, 2003.
DOI : 10.1016/S0376-8716(03)00189-3

P. Carrieri, V. Cailleton, L. Moing, V. Spire, B. Dellamonica et al., The Dynamic of Adherence to Highly Active Antiretroviral Therapy: Results From the French National APROCO Cohort, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.28, issue.3, pp.232-239, 2001.
DOI : 10.1097/00042560-200111010-00005

P. Carrieri, B. Spire, S. Duran, C. Katlama, D. Peyramond et al., Health-Related Quality of Life After 1 Year of Highly Active Antiretroviral Therapy, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.32, issue.1, pp.38-47, 2003.
DOI : 10.1097/00126334-200301010-00006

E. Celerier, J. P. Laulin, J. B. Corcuff, L. Moal, M. Simonnet et al., Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: A sensitization process, J. Neurosci, vol.21, issue.11, pp.4074-4080, 2001.

R. E. Chaisson, J. C. Keruly, and R. D. Moore, Race, Sex, Drug Use, and Progression of Human Immunodeficiency Virus Disease, New England Journal of Medicine, vol.333, issue.12, pp.333-751, 1995.
DOI : 10.1056/NEJM199509213331202

M. A. Chesney, Factors Affecting Adherence to Antiretroviral Therapy, Clinical Infectious Diseases, vol.30, issue.Supplement 2, pp.171-176, 2000.
DOI : 10.1086/313849

M. A. Chesney, M. Morin, and L. Sherr, Adherence to HIV combination therapy, Social Science & Medicine, vol.50, issue.11, pp.1599-1605, 2000.
DOI : 10.1016/S0277-9536(99)00468-2

S. Clarke, E. Keenan, M. Ryan, M. Barry, and F. Mulcahy, Directly observed anti-retroviral therapy for injection drug users with HIV infection, AIDS Read, vol.12, issue.7, pp.305-307, 2002.

A. J. Claxton, J. Cramer, and C. Pierce, A systematic review of the associations between dose regimens and medication compliance, Clinical Therapeutics, vol.23, issue.8, pp.1296-1310, 2001.
DOI : 10.1016/S0149-2918(01)80109-0

P. Compton, V. C. Charuvastra, and W. Ling, Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent, Drug and Alcohol Dependence, vol.63, issue.2, pp.139-146, 2001.
DOI : 10.1016/S0376-8716(00)00200-3

B. Conway, J. Prasad, R. Reynolds, J. Farley, M. Jones et al., Directly observed therapy for the management of HIVinfected patients in a methadone program, Clin. Infect. Dis, pp.38-402, 2004.

D. G. Cruess, S. D. Douglas, J. M. Petitto, J. Leserman, T. Ten-have et al., Association of depression, CD8+ T lymphocytes, and natural killer cell activity: Implications for morbidity and mortality in human immunodeficiency virus disease, Current Psychiatry Reports, vol.15, issue.6, pp.445-450, 2003.
DOI : 10.1007/s11920-003-0083-4

A. Duburcq, Y. Charpak, P. Blin, and L. Madec, Two years follow-up of a heroin users cohort treated with high dosage buprenorphine. Results of the SPESUB study (pharmacoepidemiologic follow-up of general practice Subutex), Rev. Epidemiol. Sante Publique, vol.48, issue.4, pp.363-373, 2000.

S. Duran, M. Saves, B. Spire, V. Cailleton, A. Sobel et al., Failure to maintain long-term adherence to highly active anti-retroviral therapy: The role of lipodystrophy, AIDS, issue.18, pp.15-2441, 2001.

S. Duran, B. Spire, F. Raffi, V. Walter, D. Bouhour et al., Self-Reported Symptoms After Initiation of a Protease Inhibitor in HIV-Infected Patients and Their Impact on Adherence to HAART, HIV Clinical Trials, vol.4, issue.9, pp.38-45, 2001.
DOI : 10.1097/00002030-199909100-00022

B. Gerbert, B. T. Maguire, T. Bleecker, T. J. Coates, and S. J. Mcphee, Primary care physicians and AIDS. Attitudinal and structural barriers to care, JAMA: The Journal of the American Medical Association, vol.266, issue.20, pp.266-2837, 1991.
DOI : 10.1001/jama.266.20.2837

G. Gerra, F. Borella, A. Zaimovic, G. Moi, M. Bussandri et al., Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome, Drug and Alcohol Dependence, vol.75, issue.1, pp.37-45, 2004.
DOI : 10.1016/j.drugalcdep.2003.11.017

D. R. Gibson, J. L. Sorensen, L. Wermuth, and G. Bernal, Families Are Helped by Drug Treatment, International Journal of the Addictions, vol.5, issue.8, pp.27-961, 1992.
DOI : 10.3109/00952998709001511

A. L. Gifford, J. E. Bormann, M. J. Shively, B. C. Wright, D. D. Richman et al., Predictors of Self-Reported Adherence and Plasma HIV Concentrations in Patients on Multidrug Antiretroviral Regimens, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.23, issue.5, pp.386-395, 2000.
DOI : 10.1097/00126334-200004150-00005

E. T. Golub, J. A. Astemborski, D. R. Hoover, J. C. Anthony, D. Vlahov et al., Psychological Distress and Progression to AIDS in a Cohort of Injection Drug Users, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.32, issue.4, pp.429-434, 2003.
DOI : 10.1097/00126334-200304010-00013

J. S. Gonzalez, F. J. Penedo, M. H. Antoni, R. E. Duran, S. Mcpherson-baker et al., Social Support, Positive States of Mind, and HIV Treatment Adherence in Men and Women Living With HIV/AIDS., Health Psychology, vol.23, issue.4, pp.413-418, 2004.
DOI : 10.1037/0278-6133.23.4.413

M. N. Gourevitch and G. H. Friedland, Interactions between methadone and medications used to treat HIV infection: A review, 2000.

R. Hogg, B. Yip, K. Chan, M. Shaughnessy, and J. Montaner, Non-adherence to triple combination therapy is predictive of AIDS progression and death in HIV-positive men and women, Paper presented at the XIIIth International AIDS conference, 2000.

R. L. Hubbard, S. G. Craddock, and J. Anderson, Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS), Journal of Substance Abuse Treatment, vol.25, issue.3, pp.125-134, 2003.
DOI : 10.1016/S0740-5472(03)00130-2

J. R. Ickovics, M. E. Hamburger, D. Vlahov, E. E. Schoenbaum, P. Schuman et al., Mortality, CD4 Cell Count Decline, and Depressive Symptoms Among HIV-Seropositive Women, JAMA, vol.285, issue.11, pp.285-1466, 2001.
DOI : 10.1001/jama.285.11.1466

J. R. Ickovics and C. S. Meade, Adherence to anti-retroviral therapy among patients with HIV: A critical link between behavioral and biomedical sciences, J. Acquir. Immune Defic. Syndr, pp.31-98, 2002.

J. Kakko, K. D. Svanborg, M. J. Kreek, and M. Heilig, 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial, The Lancet, vol.361, issue.9358, pp.361-662, 2003.
DOI : 10.1016/S0140-6736(03)12600-1

S. C. Kalichman, B. Ramachandran, and S. Catz, Adherence to combination antiretroviral therapies in HIV patients of low health literacy, Journal of General Internal Medicine, vol.154, issue.5, pp.267-273, 1999.
DOI : 10.1046/j.1525-1497.1999.00334.x

F. Kapadia, D. Vlahov, R. M. Donahoe, and G. Friedland, The Role of Substance Abuse in HIV Disease Progression: Reconciling Differences from Laboratory and Epidemiologic Investigations, Clinical Infectious Diseases, vol.41, issue.7, pp.41-1027, 2005.
DOI : 10.1086/433175

D. A. Katzenstein, Adherence as a particular issue with protease inhibitors, Journal of the Association of Nurses in AIDS Care, vol.8, pp.10-17, 1997.
DOI : 10.1016/S1055-3290(97)80003-9

T. Kerr, A. Palepu, G. Barness, J. Walsh, R. Hogg et al., Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver, Antivir. Ther, vol.9, issue.3, pp.407-414, 2004.

C. A. Kleeberger, J. Buechner, F. Palella, R. Detels, S. Riddler et al., Changes in adherence to highly active antiretroviral therapy medications in the Multicenter AIDS Cohort Study*, AIDS, vol.18, issue.4, pp.683-688, 2004.
DOI : 10.1097/00002030-200403050-00013

C. A. Kleeberger, J. P. Phair, S. A. Strathdee, R. Detels, L. Kingsley et al., Determinants of Heterogeneous Adherence to HIV-Antiretroviral Therapies in the Multicenter AIDS Cohort Study, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.26, issue.1, pp.82-92, 2001.
DOI : 10.1097/00126334-200101010-00012

A. Kott, E. Habel, and W. Nottingham, Analysis of behavioral patterns in five cohorts of patients retained in methadone maintenance programs, Mt. Sinai J. Med, vol.68, issue.1, pp.46-54, 2001.

E. Lloyd-smith, E. Brodkin, E. Wood, T. Kerr, M. W. Tyndall et al., Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia, AIDS, vol.20, issue.3, pp.445-450, 2006.
DOI : 10.1097/01.aids.0000206508.32030.92

G. M. Lucas, K. A. Gebo, R. E. Chaisson, and R. D. Moore, Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic, AIDS, vol.16, issue.5, pp.16-767, 2002.
DOI : 10.1097/00002030-200203290-00012

G. M. Lucas, M. Griswold, K. A. Gebo, J. Keruly, R. E. Chaisson et al., Illicit Drug Use and HIV-1 Disease Progression: A Longitudinal Study in the Era of Highly Active Antiretroviral Therapy, American Journal of Epidemiology, vol.163, issue.5, pp.412-420, 2006.
DOI : 10.1093/aje/kwj059

G. M. Lucas, P. J. Weidle, S. Hader, and R. D. Moore, Directly administered anti-retroviral therapy in an urban methadone maintenance clinic: A nonrandomized comparative study, Clin. Infect. Dis, pp.38-409, 2004.

C. M. Lyles, J. B. Margolick, J. Astemborski, N. M. Graham, J. C. Anthony et al., The influence of drug use patterns on the rate of CD4+ lymphocyte decline among HIV-1-infected injecting drug users, AIDS, vol.11, issue.10, pp.11-1255, 1997.
DOI : 10.1097/00002030-199710000-00009

L. Maisels, J. Steinberg, and C. Tobias, An Investigation of Why Eligible Patients Do Not Receive HAART, AIDS Patient Care and STDs, vol.15, issue.4, pp.185-191, 2001.
DOI : 10.1089/10872910151133701

C. Marimoutou, P. Carrieri, I. Poizot-martin, A. Loundou, F. Tremolieres et al., Hospitalization for depressive syndrome in a cohort of HIV-infected patients contaminated through injecting drug use: MANIF 2000 cohort, France, 1995-1999, AIDS Care, vol.143, issue.5, pp.729-734, 1995.
DOI : 10.3109/10826089909037245

C. Marzolini, N. Troillet, A. Telenti, P. Baumann, L. A. Decosterd et al., Efavirenz decreases methadone blood concentrations, AIDS, vol.14, issue.9, pp.14-1291, 2000.
DOI : 10.1097/00002030-200006160-00036

E. F. Mccance-katz, P. M. Rainey, P. Smith, G. Morse, G. Friedland et al., Drug Interactions between Opioids and Antiretroviral Medications: Interaction between Methadone, LAAM, and Nelfinavir, American Journal on Addictions, vol.13, issue.2, pp.163-180, 2004.
DOI : 10.1080/10550490490436037

A. T. Mclellan, I. O. Arndt, D. S. Metzger, G. E. Woody, and C. P. O-'brien, The effects of psychosocial services in substance abuse treatment, JAMA, issue.15, pp.269-1953, 1993.

D. S. Metzger, G. E. Woody, A. T. Mclellan, C. P. O-'brien, P. Druley et al., Human immunodeficiency virus seroconversion among intravenous drug users in-and out-of-treatment: An 18-month prospective follow-up, J. Acquir. Immune Defic. Syndr, vol.6, issue.9, pp.1049-1056, 1993.

J. P. Moatti, M. P. Carrieri, B. Spire, J. A. Gastaut, J. P. Cassuto et al., Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment, AIDS, vol.14, issue.2, pp.151-155, 2000.
DOI : 10.1097/00002030-200001280-00010

R. D. Moore, J. C. Keruly, and R. E. Chaisson, Differences in HIV Disease Progression by Injecting Drug Use in HIV-Infected Persons in Care, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.35, issue.1, pp.46-51, 2004.
DOI : 10.1097/00126334-200401010-00006

A. Palepu, N. J. Horton, N. Tibbetts, S. Meli, and J. H. Samet, Uptake and adherence to highly active anti-retroviral therapy among HIV-infected people with alcohol and other substance use problems: The impact of substance abuse treatment, Addiction, issue.3, pp.99-361, 2004.

A. Palepu, M. W. Tyndall, R. Joy, T. Kerr, E. Wood et al., Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: The role of methadone maintenance therapy, Drug and Alcohol Dependence, vol.84, issue.2, pp.188-194, 2006.
DOI : 10.1016/j.drugalcdep.2006.02.003

C. A. Pinheiro, J. C. De-carvalho-leite, M. L. Drachler, and V. L. Silveira, Factors associated with adherence to anti-retroviral therapy in HIV/AIDS patients: A cross-sectional study in Southern Brazil, Braz. J. Med. Biol. Res, issue.10, pp.35-1173, 2002.

C. Pradier, L. Bentz, B. Spire, C. Tourette-turgis, M. Morin et al., Efficacy of an educational and counseling intervention on adherence to highly active anti-retroviral therapy: French prospective controlled study, HIV Clin. Trials, vol.4, issue.2, pp.121-131, 2003.

R. R. Reno and L. S. Aiken, Life Activities and Life Quality of Heroin Addicts In and Out of Methadone Treatment, International Journal of the Addictions, vol.56, issue.3, pp.211-232, 1993.
DOI : 10.1300/J251v02n01_02

A. Richter and B. Loomis, Health and Economic Impacts of an HIV Intervention in Out of Treatment Substance Abusers: Evidence from a Dynamic Model, Health Care Management Science, vol.36, issue.7, pp.67-79, 2005.
DOI : 10.1007/s10729-005-5218-1

A. M. Rompalo, N. Shah, J. B. Margolick, H. Farzadegan, J. Arnsten et al., Evaluation of Possible Effects of Continued Drug Use on HIV Progression among Women, International Journal of STD & AIDS, vol.28, issue.17, pp.322-327, 2004.
DOI : 10.1177/095646240401500510

J. Russell, S. Krantz, and S. Neville, The Patient-Provider Relationship and Adherence to Highly Active Antiretroviral Therapy, Journal of the Association of Nurses in AIDS care, vol.15, issue.5, pp.40-47, 2004.
DOI : 10.1177/1055329004269283

U. Sambamoorthi, L. A. Warner, S. Crystal, and J. Walkup, Drug abuse, methadone treatment, and health services use among injection drug users with AIDS, Drug and Alcohol Dependence, vol.60, issue.1, pp.77-89, 2000.
DOI : 10.1016/S0376-8716(00)80010-1

A. K. Sethi, D. D. Celentano, S. J. Gange, R. D. Moore, and J. E. Gallant, Association between adherence to anti-retroviral therapy and human immunodeficiency virus drug resistance, Clin. Infect. Dis, issue.8, pp.37-1112, 2003.

A. Shakarishvili, L. K. Dubovskaya, L. S. Zohrabyan, J. S. St-lawrence, S. O. Aral et al., Sex work, drug use, HIV infection, and spread of sexually transmitted infections in Moscow, Russian Federation, The Lancet, vol.366, issue.9479, pp.366-57, 2005.
DOI : 10.1016/S0140-6736(05)66828-6

J. M. Simoni, P. A. Frick, D. W. Pantalone, and B. J. Turner, Antiretroviral adherence interventions: A review of current literature and ongoing studies, Top. HIV Med, vol.11, issue.6, pp.185-198, 2003.

N. Singh, C. Squier, C. Sivek, M. Wagener, M. Nguyen et al., Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance, AIDS Care, vol.8, issue.3, pp.261-269, 1996.
DOI : 10.1080/09540129650125696

B. Spire, S. Duran, M. Souville, C. Leport, F. Raffi et al., Adherence to highly active anti-retroviral therapy (HAART) in HIV-infected patients: From a predictive to a dynamic approach, Soc. Sci. Med

B. Spire, S. Duran, M. Souville, C. Leport, F. Raffi et al., Adherence to highly active anti-retroviral therapies (HAART) in HIVinfected patients: From a predictive to a dynamic approach, Soc. Sci. Med, issue.10, pp.54-1481, 2002.

V. Stone, J. Clarke, J. Lovell, K. Steger, L. Hirschhorn et al., HIV/AIDS patients??? perspectives on adhering to regimens containing protease inhibitors, Journal of General Internal Medicine, vol.311, issue.9, pp.586-593, 1998.
DOI : 10.1046/j.1525-1497.1998.00180.x

V. E. Stone, Strategies for Optimizing Adherence to Highly Active Antiretroviral Therapy: Lessons from Research and Clinical Practice, Clinical Infectious Diseases, vol.33, issue.6, pp.865-872, 2001.
DOI : 10.1086/322698

J. S. Tucker, M. A. Burnam, C. D. Sherbourne, F. Y. Kung, and A. L. Gifford, Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection, The American Journal of Medicine, vol.114, issue.7, pp.573-580, 2003.
DOI : 10.1016/S0002-9343(03)00093-7

B. J. Turner, C. Laine, L. Cosler, and W. W. Hauck, Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users, Journal of General Internal Medicine, vol.23, issue.4, pp.248-257, 2003.
DOI : 10.1046/j.1525-1497.2003.20122.x

G. J. Wagner and G. W. Ryan, Relationship Between Routinization of Daily Behaviors and Medication Adherence in HIV-Positive Drug Users, AIDS Patient Care and STDs, vol.18, issue.7, pp.385-393, 2004.
DOI : 10.1089/1087291041518238

J. C. Walsh, A. L. Pozniak, M. R. Nelson, S. Mandalia, and B. G. Gazzard, Virologic Rebound on HAART in the Context of Low Treatment Adherence Is Associated With a Low Prevalence of Antiretroviral Drug Resistance, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.30, issue.3, pp.278-287, 2002.
DOI : 10.1097/00126334-200207010-00003

E. Wood, R. S. Hogg, T. Kerr, A. Palepu, R. Zhang et al., Impact of accessing methadone on the time to initiating HIV treatment among anti-retroviral-naive HIV-infected injection drug users, J. S. AIDS, issue.8, pp.19-837, 2005.

E. Wood, R. S. Hogg, B. Yip, P. R. Harrigan, M. V. Shaughnessy et al., The Impact of Adherence on CD4 Cell Count Responses Among HIV-Infected Patients, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.35, issue.3, pp.261-268, 2004.
DOI : 10.1097/00126334-200403010-00006

E. Wood, J. S. Montaner, B. Yip, M. W. Tyndall, M. T. Schechter et al., Adherence and plasma HIV RNA responses to highly active anti-retroviral therapy among HIV-1 infected injection drug users, Cmaj, issue.7, pp.169-656, 2003.

E. Woolridge, S. Barton, J. Samuel, J. Osorio, A. Dougherty et al., Cannabis Use in HIV for Pain and Other Medical Symptoms, Journal of Pain and Symptom Management, vol.29, issue.4, pp.358-367, 2005.
DOI : 10.1016/j.jpainsymman.2004.07.011

A. W. Wu, A. Ammassari, and A. Antinori, Adherence to Antiretroviral Therapy: Where Are We, and Where Do We Go From Here?, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.31, 2002.
DOI : 10.1097/00126334-200212153-00001

L. W. Yun, M. Maravi, J. S. Kobayashi, P. L. Barton, and A. J. Davidson, Antidepressant Treatment Improves Adherence to Antiretroviral Therapy Among Depressed HIV-Infected Patients, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.38, issue.4, pp.432-438, 2005.
DOI : 10.1097/01.qai.0000147524.19122.fd